3 results
Approved WMOCompleted
The primary objective(s) of this study is:- To determine the relative bioavailability of etoricoxib 120 mg tablets manufactured at Frosst Iberica, Spain and Elkton, VA, USA.
Approved WMORecruiting
The objective of this trial is to demonstrate a suitable benefit/risk profile to support a subsequent trial of the safety and effectiveness of the IAB to achieve its intended purpose: The IAB is indicated for bronchoscopic treatment of adults with…
Approved WMORecruiting
To assess the short term and medium term weight loss after bariatric surgery compared to conservative therapy, to determine the prevalence and the effect of weight loss on obesity associated morbidity in adolescence, to measure the effect of…